Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gastroesophageal Cancer × relatlimab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 17 Recurrence 4 Neoplasms 4 Stomach Neoplasms 3 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Advanced Cancer 3 Uveal Melanoma 2 Squamous Cell Carcinoma of Head and Neck 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2 Turcot syndrome 1 Tertiary Lymphoid Structures 1 Spinocerebellar Degenerations 1 Skin Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Nasopharyngeal Carcinoma 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Microsatellite Unstable Colorectal Cancer 1 Microsatellite Instability 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Large-Cell, Anaplastic 1

Interventions

relatlimab 1 Ramucirumab 1 Nivolumab 1 Drug Therapy 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03610711 2025-12-22

REACTION

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Active not recruiting

Gastrointestinal

Gastroesophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡